Immune-mediated colitis after immune checkpoint inhibitor therapy
Sophie Giesler, R. Kirk Riemer, Theresa Lowinus, Robert Zeiser
Abstract
antibodies. Given that systemic immunosuppression might impair antitumor immune responses, novel therapeutic approaches are urgently needed.
Topics & Concepts
Immune systemColitisImmunologyImmune checkpointMedicineImmunotherapyMicroscopic ColitisCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies